MiniMed Group annual revenue
2023
2024
2025
2026
MiniMed Group reported $3.10B in revenue for fiscal 2026, an increase of 14.25% from the previous fiscal year.
View full MiniMed Group company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | $3.10B | $387.0M | +14.25% |
| 2025 | 2025-04-25 | $2.71B | $246.0M | +9.96% |
| 2024 | 2024-04-26 | $2.47B | $224.0M | +9.98% |
| 2023 | 2023-04-30 | $2.25B | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | $843.0M | $120.0M | +16.60% |
| Q4 2026 | 2026-04-24 | $837.0M | $113.0M | +15.61% |
| Q3 2026 | 2026-01-31 | $790.0M | $103.0M | +14.99% |
| Q3 2026 | 2026-01-23 | $790.0M | $103.0M | +14.99% |
| Q2 2026 | 2025-10-24 | $752.0M | — | — |
| Q1 2026 | 2025-07-25 | $723.0M | — | — |
| Q4 2025 | 2025-04-25 | $724.0M | — | — |
| Q3 2025 | 2025-01-24 | $687.0M | — | — |
MiniMed Group's latest reported quarter, Q1 2027, generated $843.0M in revenue, an increase of 16.60% year over year.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review MiniMed Group source filings ↗